Dagmar Kühnhardt

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

Peter Borchmann, Helen Goergen, Carsten Kobe et al. · The Lancet · 2017 · 372 citations

Positron Emission Tomography, Advanced-stage Hodgkin, Lymphoid Neoplasia +9

Association of IL-6, Hypothalamus-Pituitary-Adrenal Axis Function, and Depression in Patients With Cancer

Christian Jehn, Dagmar Kühnhardt, Andrea Bartholomae et al. · Integrative Cancer Therapies · 2010 · 68 citations · Full text

PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial

Stefanie Kreissl, Helen Goergen, Ina Buehnen et al. · The Lancet Haematology · 2021 · 65 citations

Follow-up Analysis, Lymphoid Neoplasia, Oncologic Imaging +6

A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines

Peter Schmid, Dagmar Kühnhardt, Philipp Kiewe et al. · Annals of Oncology · 2008 · 52 citations

Metastatic Breast Cancer, Breast Oncology, Phase I/ii Study +8

Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors

Peter Schmid, Philipp Kiewe, K. Possinger et al. · Annals of Oncology · 2009 · 41 citations · Full text

Solid Tumors, Medicine, Pharmacology +9